Related Experiment Video
Updated: May 17, 2026

Isolation of Low Endotoxin Content Extracellular Vesicles Derived from Cancer Cell Lines
Published on: February 17, 2023
Endotoxin removal and prevention for pre-clinical biologics production
Anne Serdakowski London1, Brendan Kerins, William R Tschantz
1Novartis Institutes for Biomedical Research, Protein Production and Antibodies, Cambridge, MA, USA. Anne.London@novartis.com
Abstract:
The removal of endotoxin from protein solutions and its prevention are key to the success of recombinant protein production due to the possible pyogenic response in mammals caused by contaminated samples. In the pre-clinical situation, protein production is often carried out in a non-good manufacturing practice (GMP) setting, utilizing bacterial DNA for transient transfection and non-validated cleaning techniques. Here, we present our findings evaluating various options for endotoxin removal, and propose strategies for endotoxin prevention with emphasis on chromatographic separations, endotoxin-removing membranes and on-column wash strategies.
Related Concept Videos
Vaccine Production
Upstream Processing
Production of Pharmaceuticals
Production of Biopesticides
Production of Antibiotics
Biological Methods for Microbial Control

